Valiant Organics Limited (VALIANTORG.NS)
INR 327.3
(0.78%)
INR 327.3
(0.78%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 840 Million | 2.37 Billion | -324.72 Million | 1.12 Billion | 1.61 Billion | 1.21 Billion |
| Net Income | -86.93 Million | 1.37 Billion | 1.76 Billion | 1.84 Billion | 1.82 Billion | 6.92 Billion |
| Depreciation & Amortization | 349.24 Million | 291.89 Million | 296.18 Million | 212.39 Million | 154.42 Million | -26.27 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 11.58 Million | - | - | - | - | - |
| Change in working capital | 535.81 Million | 886.67 Million | -2.02 Billion | -488.49 Million | 221.09 Million | 1.71 Billion |
| Other non-cash items | 212.49 Million | -171.1 Million | -355.29 Million | -443.44 Million | -590.95 Million | -7.39 Billion |
| Investing Cash Flow | -649.87 Million | -1.42 Billion | -1.22 Billion | -1.56 Billion | -1.79 Billion | -940.11 Million |
| Investments in PPE | -736.24 Million | -1.36 Billion | -1.2 Billion | -1.71 Billion | -2.05 Billion | -889.95 Million |
| Acquisitions | 87.69 Million | 215.82 Million | 346 Thousand | 333 Thousand | 832 Thousand | 1.33 Billion |
| Investment purchases | -10.12 Million | -329.56 Million | -21.84 Million | -131.29 Million | -42.44 Million | -16.92 Million |
| Sales/Maturities of investments | 3.47 Million | 199.36 Million | 21.5 Million | 256.27 Million | 233.13 Million | -442.2 Million |
| Other Investing Activities | 99.42 Million | -150.88 Million | -12.87 Million | 24.48 Million | 65.76 Million | -923.18 Million |
| Financing Cash Flow | -231.19 Million | -1.12 Billion | 1.66 Billion | 486.38 Million | 271.6 Million | 10.05 Million |
| Debt repayment | -38.7 Million | -896.33 Million | -1.52 Billion | -604.56 Million | -543.46 Million | -151.54 Million |
| Dividends payments | - | -122.19 Million | - | -67.88 Million | -263.63 Million | -104.72 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 160 Thousand | - | 234.4 Million | - | - | - |
| Other Financing Activities | -385.32 Million | -106.27 Million | 2.96 Billion | 1.15 Billion | 1.07 Billion | 266.33 Million |
| Accounts receivables | 449.36 Million | 666.38 Million | -1.63 Billion | -246.55 Million | 87.83 Million | -425.01 Million |
| Accounts payables | 418.48 Million | 344.01 Million | 183.15 Million | 193.19 Million | 136.03 Million | - |
| Inventory | 119.89 Million | -125.84 Million | -414.66 Million | -273.06 Million | 30.45 Million | -29.28 Million |
| Other working capital | -451.93 Million | 2.12 Million | -161.15 Million | -162.06 Million | -33.22 Million | 2.16 Billion |
| Cash at beginning of period | 77.5 Million | 250.46 Million | 128.33 Million | 76.57 Million | 36.37 Million | 125.59 Million |
| Cash at end of period | 34.82 Million | 77.5 Million | 250.46 Million | 128.33 Million | 126.79 Million | 36.37 Million |
| Capital Expenditure | -736.24 Million | -1.36 Billion | -1.2 Billion | -1.71 Billion | -2.05 Billion | -889.95 Million |
| Effect of forex changes on cash | - | - | - | 1000.00 | -50.21 Million | -371.84 Million |
| Net cash flow / Change in cash | -42.68 Million | -172.96 Million | 122.13 Million | 51.75 Million | 90.41 Million | -89.21 Million |
| Free Cash Flow | 103.76 Million | 1.01 Billion | -1.53 Billion | -584.42 Million | -438.48 Million | 322.74 Million |
| Breakdown | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -6.19 Million | -86.93 Million | -172.19 Million | -78.93 Million | 42.97 Million | 124.24 Million |
| Depreciation & Amortization | - | 349.24 Million | - | 85.97 Million | 88.88 Million | 86.7 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | 11.58 Million | - | - | - |
| Change in working capital | - | 535.81 Million | - | - | - | - |
| Other non-cash items | 6.19 Million | 212.49 Million | 160.6 Million | 78.93 Million | -42.97 Million | -124.24 Million |
| Investing Cash Flow | - | -649.87 Million | - | - | - | - |
| Investments in PPE | - | -736.24 Million | - | - | - | - |
| Acquisitions | - | 87.69 Million | - | - | - | - |
| Investment purchases | - | -10.12 Million | - | - | - | - |
| Sales/Maturities of investments | - | 3.47 Million | - | - | - | - |
| Other Investing Activities | - | 99.42 Million | - | - | - | - |
| Financing Cash Flow | - | -231.19 Million | - | - | - | - |
| Debt repayment | - | -38.7 Million | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | 160 Thousand | - | - | - | - |
| Other Financing Activities | - | -385.32 Million | - | - | - | - |
| Accounts receivables | - | 449.36 Million | - | - | - | - |
| Accounts payables | - | 418.48 Million | - | - | - | - |
| Inventory | - | 119.89 Million | - | - | - | - |
| Other working capital | - | -451.93 Million | - | - | - | - |
| Cash at beginning of period | - | 77.5 Million | - | 25.52 Million | -152.24 Million | 77.5 Million |
| Cash at end of period | - | 34.82 Million | - | 197.47 Million | 25.52 Million | 250.92 Million |
| Capital Expenditure | - | -736.24 Million | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | - | -42.68 Million | - | 171.94 Million | 177.77 Million | 173.41 Million |
| Free Cash Flow | - | 103.76 Million | - | 171.94 Million | 177.77 Million | 173.41 Million |
0FF
PHI1
AVTNPL
SANN
RVMDW
ERT